A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
12/2004
12/02/2004	US20040241173 Formed via hydrolysis; antibiotic resistance; may contain penicillins, cephalosporins, quinolones, fluoroquinolones, macrolides, lincosamines, carbepenems, conobactams, aminoglycosides, glycopeptides, tetracyclines, sulfonamides, rifampin, oxazolidonones, and streptogramins
12/02/2004	US20040241097 Diagnosis marker
12/02/2004	US20040241095 Complex containing cyanine dyes; supplying to target tumor cells
12/02/2004	US20040241094 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
12/02/2004	US20040241093 Mixture of hydrocolloid stabilizer and sugar osmosis agent; adjust viscosity of body fluid
12/02/2004	US20040241092 Induction pain; administering an analgesics; calibration
12/02/2004	US20040241091 Methods and compositions for inhibiting cellulollytic symbionts
12/02/2004	US20040241090 Compounds, compositions and methods for medical imaging of neuropsychiatric disorders
12/02/2004	US20040241089 Systems and methods for detecting vulnerable plaque
12/02/2004	DE10061195B4 Verwendung von Abformmassen zur Herstellung von Behandlungsvorrichtungen Use of impression materials for the production of treatment devices
12/01/2004	EP1482041A1 Nnl6 tie receptor tyrosine kinase ligand homologues
12/01/2004	EP1482040A2 NL3 TIE receptor tyrosine kinase ligand homologues
12/01/2004	EP1481633A1 Method for detecting a substance of metabolism of a living body and apparatus therefor
12/01/2004	EP1481243A1 Therapeutic properties of oils
12/01/2004	EP1481093A2 MODULATION OF TYPE II&bgr; PHOSPHOINOSITIDE PHOSPHATE KINASE
12/01/2004	EP1480979A2 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
12/01/2004	EP1480691A2 Agglomerated particles for aerosol drug delivery
12/01/2004	EP1480683A2 Near infrared fluorescent contrast agent and method for fluorescence imaging
12/01/2004	EP1059943B1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
12/01/2004	CN1551872A Biologically active methylene blue derivatives
12/01/2004	CN1177806C Diagnostic imaging contrast agents with extended blood retention
11/2004
11/30/2004	US6825204 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/30/2004	US6824760 Imaging agents, precursors thereof and methods of manufacture
11/25/2004	WO2004102192A1 A non-invasive assay for the assessment of functioning and/or structure of the gut
11/25/2004	WO2004101072A1 Cns chloride modulation and uses thereof
11/25/2004	WO2004100998A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/25/2004	WO2004100996A1 Vitronectin receptor antagonist compounds and their use in the preparation of radiopharmaceuticals
11/25/2004	WO2004100769A2 Methods for using gadolinium as a contrast media
11/25/2004	WO2004069284A3 Ultrasound contrast agents and process for the preparation thereof
11/25/2004	WO2004067483A3 Chelating agents with lipophilic carriers
11/25/2004	WO2003090599A3 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
11/25/2004	WO2002047537A3 Compositions and methods for in situ and in vivo imaging of cells and tissues
11/25/2004	US20040236268 Method and apparatus for enhancement of transdermal transport
11/25/2004	US20040236211 Marker or filler forming fluid
11/25/2004	US20040236208 Detection results of gadolinium using magnetic resonance imaging on cross-sections of edges of tissues
11/25/2004	US20040235801 Therapy for stroke
11/25/2004	US20040235067 Stain-directed molecular analysis for cancer prognosis and diagnosis
11/25/2004	US20040235065 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/25/2004	US20040234455 Dna sequences encoding detectable cytotoxic protein generating signal; tumor imaging; gene expression
11/25/2004	US20040234454 Pathological tissue detection and treatment employing targeted benzoindole optical agents
11/25/2004	US20040234452 monitoring metabolism sensitivity to pyrimidine drugs such as 5-fluorouracil; labeling with isotopes
11/25/2004	CA2526031A1 Sugar breath test and sugar absorption test for assessment of gut function
11/25/2004	CA2525396A1 Vitronectin receptor antagonist compounds and their use in the preparation of radiopharmaceuticals
11/25/2004	CA2525369A1 Methods for using gadolinium as a contrast media
11/25/2004	CA2524883A1 Potassium-chloride cotransporter kcc2 modulation for treatment of pain
11/24/2004	EP1479689A1 Peptide complex
11/24/2004	EP1478667A1 Anti-human tenascin monoclonal antibody
11/24/2004	EP1478407A1 Use of 13c labelled substance for measuring lung function
11/24/2004	EP1478405A2 Beta-homolysine conjugates and their use as transport enhancer
11/24/2004	EP1478361A2 Arylsulfone derivatives
11/24/2004	EP1478276A2 Novel targeted compositions for diagnostic and therapeutic use
11/24/2004	CN1549859A Fluorescent proteins
11/23/2004	US6822092 Expanded porphyrins and a method for synthesis thereof
11/23/2004	US6821725 Methods for the diagnosis and treatment of breast cancer
11/23/2004	US6821506 Site specific binding system, imaging compositions and methods
11/23/2004	US6821504 Detection of alzheimer's amyloid by magnetic resonance imaging
11/18/2004	WO2004098649A2 Apparatus and method for examining an object by means of elastically scattered x-ray radiation and contrast agent
11/18/2004	WO2004082749A3 Medical devices with enhanced ultrasonic visibility
11/18/2004	WO2004078778A3 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
11/18/2004	WO2004069193A9 Methods and compositions for inhibiting cholesterol uptake
11/18/2004	WO2004037997A3 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof
11/18/2004	US20040230122 Contrast agent and vasodilator; enhancing distinction between normally and under perfused tissue; cardiac blood flow
11/18/2004	US20040230044 MRI probes of membrane potential
11/18/2004	US20040228847 Progenitor cells and methods of using same
11/18/2004	US20040228801 Long-lived microbubbles containing fluorocarbon gas and a modifier gas for diagnostic ultrasound contrast enhancement which grow and shrink to maintain osmotic equilibrium with the physiological gas saturation of the surrounding liquid medium
11/18/2004	US20040228800 Injecting microbubbles into blood circulation, specific binding to site antigens in the coronary circulation, applying ultrasonic energy to burst the microbubbles, releasing nitrogen gas for absorption by the blood, detecting a signal; for patient has unstable plaque on blood vessel walls
11/18/2004	US20040228799 Packaging container contains a barium sulfate solutions of a different consistency, a cookie baked goods contains barium sulfate with radioactive dose of barium; use in a modified barium study, radiographic analysis
11/18/2004	US20040228797 A mixture comprising a biocompatible polymer, a biocompatible solvent, with a ratio of biocompatible polymer to the water-insoluble biocompatible contrast agent is about 0.055 or greater; forming a cohesive precipitate, inhibiting the undesired shedding of particles in vivo
11/18/2004	US20040228796 Catheter or guidewire, has an elongate body for insertion into patient body; enhancing the image-receiving detector for receiving signals
11/18/2004	US20040228795 Injecting a photosensitizing agent into the rats body, irradiating the optic nerve with a laser to damage the optic nerve; use in optic nerve disease research, glaucoma eye disorders
11/18/2004	DE10307759B3 Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel Trimeric macrocyclic substituted benzene derivatives, their preparation and use as a contrast agent, as well as pharmaceutical compositions containing them
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476428A1 Pyridyl sulfone derivatives as 5-ht6 receptor ligands
11/17/2004	EP1476198A2 Use of buckysome or carbon nanotube for drug delivery
11/17/2004	CN1547469A Paclitaxel mixed composition and water-in-oil type emulsion formulation for chemoembolization and preparation method thereof
11/16/2004	US6818742 Stable radioiodine conjugates and methods for their synthesis
11/16/2004	US6818411 Retentate chromatography and protein chip arrays with applications in biology and medicine
11/16/2004	US6818203 Complexes have critical micelle formation concentration, hydrodynamic micelle diameter, and proton relaxivity in plasma contrast media in mr imaging
11/16/2004	US6818202 Enhancement of NMR and MRI in the presence of hyperpolarized noble gases
11/16/2004	US6818201 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis
11/11/2004	WO2004097017A2 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
11/11/2004	WO2004096998A2 Nanoparticular tumor targeting and therapy
11/11/2004	WO2004096990A2 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004	WO2004096291A1 In vivo imaging using peptide derivatives
11/11/2004	WO2004096188A1 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof
11/11/2004	WO2004096152A2 In situ gelling self-reactive materials for embolization
11/11/2004	WO2004096124A2 Compositions and methods for the diagnosis and treatment of tumor
11/11/2004	WO2004044227A3 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
11/11/2004	WO2004024941A3 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
11/11/2004	US20040226055 Animal model exhibiting pathological conditions of Alzheimer's disease
11/11/2004	US20040224921 Fluorescent cobalamins and uses thereof
11/11/2004	US20040224884 drug screening; increasing bone mass without compromising bone strength or quality by administering an apototic or antiapoptotic agent that binds to the estrogen or androgen receptor without causing hormonal transcriptional activation; bone disorders
11/11/2004	US20040224347 Methods for identification, diagnosis, and treatment of breast cancer
11/11/2004	US20040224029 Particle possessing a membrane
11/11/2004	US20040223963 Method for treating ischemic stroke with melatonin
11/11/2004	US20040223914 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography
11/11/2004	US20040223913 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo.
11/11/2004	US20040223912 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	US20040223909 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	US20040221855 Methods for monitoring treatment of disease

1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 354